Grant: Canada Research Chairs
University of Toronto
$120,000.00
Polymer Chemistry
EF 2024-25
Résumé
Future electronics that will autonomously respond to local stimuli and be seamlessly integrated with the human body, opening the doors for opportunities in environmental monitoring, advanced consumer products, and health diagnostics for personalized therapy. The underpinnings of such electronics is development of new materials with a wide suite of functional properties. Organic polymers are a natural bridge between electronics and the body’s soft matter, where electronic, mechanical, and transient properties can be readily tuned. Tran will leverage polymer chemistry to develop electronic materials encoded with information for degradability, softness, and self-assembly. First, the forthcoming synthetic advancements will enable the demonstration of conjugated polymers that degrade into natural by-products with known degradation pathways. These key semiconducting and conducting organic materials are needed to advanced organic transient electronics, allowing the creation of environmentally friendly technologies with properties not achievable with inorganics. By developing a fundamental understanding of how biodegradation is influenced by the molecular design (e.g., sidechain, crystallinity), both degradation kinetic and electronic properties can be tailored to the desired targeted application. Second, the synthetic methodologies to create asymmetric electronic polymers will not only enable technologies based on electronics with ideal mechanical and chemical properties, but also spur fundamental investigations of self-assembly in rod-containing copolymer architectures. This approach may also lead to the seminal demonstration of sequence-defined conjugated polymers through solid-phase synthesis, which opens up opportunities for automated synthesis of high-performance donor-acceptor semiconducting polymers. Third, the self-assembling systems represent new platforms for free-floating device fabrication, sensors, and mimetics of biological structures. These platforms can be used to study signal transduction in a variety of model environments in vitro and in vivo and. The ability to selectively target diseased cells pathogens with these supramolecular nanomaterials will be exploited for more effective drug delivery of pharmaceutical compounds. While most bioelectronic research groups build tools from the top-down, our approach is bottom-up (i.e., use molecules to build up to a larger construct).
Programme
Canada Research Chairs
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
CRC-2023-00149
Name nom
Tran, Helen
Department département
Chemistry - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
120000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF1040404
Field of research list names en
Synthesis of materials
Field of research list names fr
Synthèse des matériaux
Socioeconomic objective list codes
RDS10799
Socioeconomic objective list names en
Health, n.e.c.
Socioeconomic objective list names fr
Santé, n.c.a.
Application title
Polymer Chemistry
Keywords
Green Chemistry; Polymer Chemistry; Device Fabrication; Peptoids; Automation; Transient Electronics; Drug Formulations
Application summary
Future electronics that will autonomously respond to local stimuli and be seamlessly integrated with the human body, opening the doors for opportunities in environmental monitoring, advanced consumer products, and health diagnostics for personalized therapy. The underpinnings of such electronics is development of new materials with a wide suite of functional properties. Organic polymers are a natural bridge between electronics and the body’s soft matter, where electronic, mechanical, and transient properties can be readily tuned. Tran will leverage polymer chemistry to develop electronic materials encoded with information for degradability, softness, and self-assembly. First, the forthcoming synthetic advancements will enable the demonstration of conjugated polymers that degrade into natural by-products with known degradation pathways. These key semiconducting and conducting organic materials are needed to advanced organic transient electronics, allowing the creation of environmentally friendly technologies with properties not achievable with inorganics. By developing a fundamental understanding of how biodegradation is influenced by the molecular design (e.g., sidechain, crystallinity), both degradation kinetic and electronic properties can be tailored to the desired targeted application. Second, the synthetic methodologies to create asymmetric electronic polymers will not only enable technologies based on electronics with ideal mechanical and chemical properties, but also spur fundamental investigations of self-assembly in rod-containing copolymer architectures. This approach may also lead to the seminal demonstration of sequence-defined conjugated polymers through solid-phase synthesis, which opens up opportunities for automated synthesis of high-performance donor-acceptor semiconducting polymers. Third, the self-assembling systems represent new platforms for free-floating device fabrication, sensors, and mimetics of biological structures. These platforms can be used to study signal transduction in a variety of model environments in vitro and in vivo and. The ability to selectively target diseased cells pathogens with these supramolecular nanomaterials will be exploited for more effective drug delivery of pharmaceutical compounds. While most bioelectronic research groups build tools from the top-down, our approach is bottom-up (i.e., use molecules to build up to a larger construct).